Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Hydrogen --- Boranes. --- Borane --- Boron hydrides --- Hydroborons --- Boron compounds --- Hydrides --- Nonmetals --- Storage --- Materials.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

see Table of Contents.

Metal-metal bonds --- Metalloboranes --- Reactivity (Chemistry) --- Liaisons métalliques --- Réactivité (Chimie) --- Boron --- Boron Compounds --- Metalloids --- Organic Chemicals --- Inorganic Chemicals --- Elements --- Chemicals and Drugs --- Inorganic Chemistry --- Chemistry --- Physical Sciences & Mathematics --- Metalloboranes. --- Boranes. --- Borane --- Boron hydrides --- Hydroborons --- Metallo-boron compounds --- Chemistry. --- Inorganic chemistry. --- Inorganic Chemistry. --- Inorganic chemistry --- Inorganic compounds --- Physical sciences --- Boron compounds --- Hydrides --- Boranes --- Chemistry, inorganic.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book describes state-of-the-art borylation chemistry using copper(I) catalysis. Enantioselective reactions are included to afford a variety of functionalized, complex organoboronate esters, which will find wide application in asymmetric synthesis, drug discovery, and material science. Organoboron compounds are recognized as useful reagents in organic synthesis; therefore, great effort has been devoted to the development of a simple, mild, and efficient method for their preparation in the past several years. However, the synthesis of functionalized organoboron compounds remains a challenging issue because known reactions often require the use of highly reactive organometallic carbon nucleophiles. This book focuses on conceptually new, formal nucleophilic copper(I)-catalyzed borylation reactions with diboron compounds that show high selectivity and excellent functional group compatibility. Theoretical studies based on density functional theory calculations to understand the reaction mechanisms have also been described. Advances in this novel borylation chemistry will allow the rapid and efficient synthesis of complex molecules with potentially interesting properties in combination with the boron functionalization process. .

Chemistry. --- Organic chemistry. --- Catalysis. --- Organic Chemistry. --- Chemistry, Organic. --- Activation (Chemistry) --- Chemistry, Physical and theoretical --- Surface chemistry --- Organic chemistry --- Chemistry --- Organic compounds --- Organoboron compounds --- Copper catalysts. --- Synthesis. --- Catalysts --- Boron organic compounds --- Boron compounds --- Organometallic compounds --- Chemistry, Organic --- Chemistry, Synthetic organic --- Organic synthesis (Chemistry) --- Synthetic organic chemistry --- Synthesis

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promising anticancer drug targeting the proteasome. This proteasome inhibitor induces cell stress and apoptosis in the cancer cells. While multiple mechanisms are likely to be involved, proteasome inhibition may prevent the degradation of pro-apoptotic factors, permitting activation of programmed cell death in neoplastic cells dependent upon the suppression of proapoptotic pathways. This monograph on bortezomib is a valuable source of information for researchers and clinicians from the fields of oncology and pharmacology, working either in academia or the pharmaceutical industry.

Antineoplastic agents. --- Multiple myeloma -- Chemotherapy. --- Multiple myeloma -- Treatment. --- Multiple myeloma --- Antineoplastic agents --- Hemostatic Disorders --- Boron Compounds --- Heterocyclic Compounds, 1-Ring --- Paraproteinemias --- Acids, Noncarboxylic --- Lymphoproliferative Disorders --- Peptide Hydrolases --- Therapeutics --- Therapeutic Uses --- Neoplasms, Plasma Cell --- Enzyme Inhibitors --- Multienzyme Complexes --- Enzymes --- Hydrolases --- Blood Protein Disorders --- Organic Chemicals --- Heterocyclic Compounds --- Acids --- Immunoproliferative Disorders --- Pharmacologic Actions --- Hemorrhagic Disorders --- Multiprotein Complexes --- Vascular Diseases --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Inorganic Chemicals --- Molecular Mechanisms of Pharmacological Action --- Neoplasms by Histologic Type --- Boronic Acids --- Multiple Myeloma --- Antineoplastic Agents --- Drug Therapy --- Proteasome Endopeptidase Complex --- Protease Inhibitors --- Pyrazines --- Chemicals and Drugs --- Immune System Diseases --- Hematologic Diseases --- Macromolecular Substances --- Chemical Actions and Uses --- Cardiovascular Diseases --- Neoplasms --- Enzymes and Coenzymes --- Diseases --- Hemic and Lymphatic Diseases --- Medicine --- Health & Biological Sciences --- Oncology --- Treatment --- Chemotherapy --- Treatment. --- Chemotherapy. --- Anticancer agents --- Antineoplastic drugs --- Antineoplastics --- Antitumor agents --- Antitumor drugs --- Cytotoxic drugs --- Inhibitors, Neoplasm --- Neoplasm inhibitors --- Kahler's disease --- Plasma cell myeloma --- Medicine. --- Cancer research. --- Pharmacology. --- Oncology. --- Apoptosis. --- Medicine & Public Health. --- Cancer Research. --- Pharmacology/Toxicology. --- Drugs --- Cancer --- B cells --- Monoclonal gammopathies --- Plasmacytoma --- Tumors --- Oncology  . --- Toxicology. --- Cytology. --- Cell biology --- Cellular biology --- Biology --- Cells --- Cytologists --- Chemicals --- Pharmacology --- Poisoning --- Poisons --- Toxicology --- Cell death --- Drug effects --- Medical pharmacology --- Medical sciences --- Pharmacy --- Cancer research --- Physiological effect